INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 158 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | +50.0% | 167 | 0.0% | 0.00% | – |
| Q2 2023 | $2 | 0.0% | 167 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | 0.0% | 167 | 0.0% | 0.00% | – |
| Q4 2022 | $2 | -99.8% | 167 | +169.4% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 62 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 62 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -75.0% | 62 | -66.5% | 0.00% | – |
| Q3 2020 | $8,000 | -33.3% | 185 | 0.0% | 0.00% | – |
| Q2 2020 | $12,000 | 0.0% | 185 | 0.0% | 0.00% | – |
| Q1 2020 | $12,000 | -47.8% | 185 | 0.0% | 0.00% | – |
| Q4 2019 | $23,000 | +64.3% | 185 | -9.8% | 0.00% | – |
| Q3 2019 | $14,000 | -12.5% | 205 | 0.0% | 0.00% | – |
| Q2 2019 | $16,000 | -23.8% | 205 | +8.5% | 0.00% | – |
| Q1 2019 | $21,000 | 0.0% | 189 | -9.6% | 0.00% | – |
| Q4 2018 | $21,000 | +16.7% | 209 | +50.4% | 0.00% | – |
| Q3 2018 | $18,000 | +50.0% | 139 | 0.0% | 0.00% | – |
| Q2 2018 | $12,000 | +33.3% | 139 | 0.0% | 0.00% | – |
| Q1 2018 | $9,000 | – | 139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |